Fig. 1
From: Novel lipometabolism biomarker for chemotherapy and immunotherapy response in breast cancer
Construction and verification of prognostic model of lipometabolism-related genes. A Tuning parameter (λ) selection cross‐validation error curve. B Distribution of LASSO coefficients for the 141 survival-related LMRGs. C Kaplan–Meier curve for internal training set. D 1, 3 and 5 year time dependent ROC curves for internal training set. E Risk score and survival time based on the LMRGs of internal training cohort. F Kaplan–Meier curve for external validation sets. G 1, 3 and 5 year time dependent ROC curves for external validation sets. H Risk score and survival time based on the LMRGs of external validation sets